Skip to main navigation Skip to search Skip to main content

[Tris(pyrazolyl)methane]ruthenium complexes capable of inhibiting cancer cell growth

  • Jesse M. Walker
  • , Alexis McEwan
  • , Roxanne Pycko
  • , Mary Lynn Tassotto
  • , Christine Gottardo
  • , John Th'ng
  • , Ruiyao Wang
  • , Gregory J. Spivak
  • Lakehead University
  • Regional Cancer Care
  • Northern Ontario School of Medicine
  • Queen's University Kingston

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

The [tris(pyrazolyl)methane]ruthenium complexes [(K3-tpm) RuCl(solv)2]PF6 [tpm = tris(pyrazolyl)methane; solv = MeCN, dmso] and [(K3-tpm)RuCl(LL)]PF6 [LL = K 2-dppe, K2-dppp, K2-dppb, (PMePh 2)2] have been prepared, characterized and screened in vitro for their antiproliferative properties against the MCF-7 (breast) and HeLa (cervical) cancer cell lines by using the MTT assay. Although the MeCN and dmso complexes showed no activity under the conditions used, the phosphane complexes exhibited remarkable cytotoxic behaviour.

Original languageEnglish
Pages (from-to)4629-4633
Number of pages5
JournalEuropean Journal of Inorganic Chemistry
Issue number31
DOIs
Publication statusPublished - Nov 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticancer agents
  • Antiproliferative assays
  • Half-sandwich complexes
  • Ruthenium
  • Tris(pyrazolyl)methane

Fingerprint

Dive into the research topics of '[Tris(pyrazolyl)methane]ruthenium complexes capable of inhibiting cancer cell growth'. Together they form a unique fingerprint.

Cite this